Path 2: Moderate BMI + Serious Health Condition BMI of 30 or higher PLUS one of these: Heart failure (ask your doctor if you have "preserved ejection fraction" type) High blood pressure that's hard to control (still above 140/90 despite 2+ medicines) Chronic kidney disease (stage 3a or higher your doctor can confirm) Path 3: Lower BMI + Heart/Stroke History BMI of 27 or higher PLUS one of these: Pre-diabetes Previous heart attack Previous stroke Peripheral artery disease with symptoms (leg pain when walking) Important timing: These requirements are based on when you FIRST started the GLP-1 medication not your current weight or health
Sciacca MFM, Naletova I, Giuffrida ML, Attanasio F (2022) Semax, a synthetic regulatory peptide, affects copper-induced abeta aggregation and amyloid formation in artificial membrane models
Reaches the same tissue depth as the device, at the exact moment fat cells are most disrupted and receptive
Dihexa was designed by researchers at Washington State University as a metabolically stable analog of Angiotensin IV
Researchers are exploring whether GLP-1 medications used for diabetes and weight loss could treat Alzheimers and addiction, but public concerns persist about long-term safety
Response variability between individuals can reach 4060%, driven partly by genetic variations in GLP-1 receptor expression, GIPR sensitivity, and metabolic clearance pathways
